Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Multibacillary Leprosy (MetLep)
NCT05243654Phase 2Recruiting
- Sponsor
- OUCRU Indonesia
- Start
- Oct 2022
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of metformin in multibacillary leprosy, sponsored by OUCRU Indonesia. Started Oct 2022; status: recruiting.
02
Drugs
metformin
03
Conditions
multibacillary leprosy
Beyond the preview
Go deeper on NCT05243654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05243654.